Andrew Edgecliffe-Johnson of the Financial Times writes Thursday that Bloomberg LP is joining forces with an online network for doctors to launch a service allowing investors in pharmaceutical companies to monitor and solicit physicians’ opinions on new drugs, medical devices and therapies.
“Daniel Palestrant, chief executive of Sermo, said he expected doctors to welcome the chance to share their opinions with investors. ‘The community is happiest when its voice is being heard,’ he said.
“Sachin Roopani, who developed Bloomberg’s healthcare service, said the Healthcare Exchange would provide investors with faster responses from a larger group than existing expert matching services.
“Bloomberg, which will share revenues from the service with Sermo, was looking to develop similar products for other industries, he added.”
Read more here.
The union that represents editorial staffers at Bloomberg Industry Group sent issued the following in…
City AM, a publication covering London business news, has confirmed it is ending its Monday…
Kimberly Johnson, former election editor at The Wall Street Journal, wrote a goodbye email to…
X has hired John Stoll, a former editor and Detroit bureau chief at The Wall…
The Dayton Business Journal seeks a driven data reporter/researcher in a booming market. This position…
The Real Deal has promoted Cara Eisenpress to managing features editor. Eisenpress started as features editor at…
View Comments
Their terminal is phenomenal, and this new service is intriguing - as someone who tracks pharmaceutical stocks for a living, it will be interesting to see what sort of insights this might provide.